Change begins here
Once you have taken the Respiragene™ test, you will know your personal risk of developing lung cancer. Use that information to get the help you need to quit and better monitor your health.
Molecular Diagnositics Laboratories, LLC ("MDL"), the clinical lab division of PhD Diagnostics, has specifically developed and validated the Respiragene™ test for processing and sale in the United States. MDL is a leading-edge developer and provider of genetic-based tests, and is located in Covington, Kentucky where it operates a laboratory facility in full compliance with the CLIA (Clinical Laboratory Improvement Amendments) regulatory regime for reference labs. (CLIA # 18D1100471 and New York Clinical Laboratory Permit (PFI:-7902)).
PhD Diagnostics and MDL are part of the bioLOGIC LLC network, which is an accelerator for innovative products and services in the diagnostic, therapeutic and medical instrumentation sectors.
Please see www.mdl-labs.com for greater detail on the laboratory regulatory status and contact details.
Click here to get a sample of what your results will look like
